HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sigma Factor SigB Is Crucial to Mediate Staphylococcus aureus Adaptation during Chronic Infections.

Abstract
Staphylococcus aureus is a major human pathogen that causes a range of infections from acute invasive to chronic and difficult-to-treat. Infection strategies associated with persisting S. aureus infections are bacterial host cell invasion and the bacterial ability to dynamically change phenotypes from the aggressive wild-type to small colony variants (SCVs), which are adapted for intracellular long-term persistence. The underlying mechanisms of the bacterial switching and adaptation mechanisms appear to be very dynamic, but are largely unknown. Here, we analyzed the role and the crosstalk of the global S. aureus regulators agr, sarA and SigB by generating single, double and triple mutants, and testing them with proteome analysis and in different in vitro and in vivo infection models. We were able to demonstrate that SigB is the crucial factor for adaptation in chronic infections. During acute infection, the bacteria require the simultaneous action of the agr and sarA loci to defend against invading immune cells by causing inflammation and cytotoxicity and to escape from phagosomes in their host cells that enable them to settle an infection at high bacterial density. To persist intracellularly the bacteria subsequently need to silence agr and sarA. Indeed agr and sarA deletion mutants expressed a much lower number of virulence factors and could persist at high numbers intracellularly. SigB plays a crucial function to promote bacterial intracellular persistence. In fact, ΔsigB-mutants did not generate SCVs and were completely cleared by the host cells within a few days. In this study we identified SigB as an essential factor that enables the bacteria to switch from the highly aggressive phenotype that settles an acute infection to a silent SCV-phenotype that allows for long-term intracellular persistence. Consequently, the SigB-operon represents a possible target to develop preventive and therapeutic strategies against chronic and therapy-refractory infections.
AuthorsLorena Tuchscherr, Markus Bischoff, Santiago M Lattar, Mariangeles Noto Llana, Henrike Pförtner, Silke Niemann, Jennifer Geraci, Hélène Van de Vyver, Martin J Fraunholz, Ambrose L Cheung, Mathias Herrmann, Uwe Völker, Daniel O Sordelli, Georg Peters, Bettina Löffler
JournalPLoS pathogens (PLoS Pathog) Vol. 11 Issue 4 Pg. e1004870 (Apr 2015) ISSN: 1553-7374 [Electronic] United States
PMID25923704 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Agr protein, Staphylococcus aureus
  • Bacterial Proteins
  • SarA protein, Staphylococcus aureus
  • SigB protein, Bacteria
  • Sigma Factor
  • Trans-Activators
Topics
  • Adaptation, Physiological
  • Animals
  • Bacterial Proteins (genetics, metabolism)
  • Cell Line
  • Cells, Cultured
  • Endothelium, Vascular (cytology, immunology, microbiology, pathology)
  • Gene Deletion
  • Host-Pathogen Interactions
  • Human Umbilical Vein Endothelial Cells (cytology, immunology, microbiology, pathology)
  • Humans
  • Mice
  • Mice, Inbred BALB C
  • Mutation
  • Neutrophils (cytology, immunology, microbiology, pathology)
  • Osteoblasts (cytology, immunology, microbiology, pathology)
  • Proteomics
  • Sigma Factor (genetics, metabolism)
  • Staphylococcal Infections (immunology, metabolism, microbiology, pathology)
  • Staphylococcus aureus (immunology, metabolism, physiology)
  • Time Factors
  • Trans-Activators (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: